×
About 17,455 results

ALLMedicine™ Atopic Dermatitis Center

Research & Reviews  5,286 results

Vitamin D deficiency osteomalacia triggered by long-term social withdrawal and unbalanc...
https://doi.org/10.1097/MD.0000000000028589 10.1136/bcr-2014-204558
Medicine Iwamoto Y, Tatsumi F et. al.

Jan 15th, 2022 - Osteomalacia is caused by an increase in the number of osteoids owing to mineralization failure. There are various causes of osteomalacia, such as hypophosphatemia due to excess production of fibroblast growth factor 23, vitamin D deficiency, insu...

Hand eczema and atopic dermatitis closely linked
https://www.mdedge.com/dermatology/article/250751/atopic-dermatitis/hand-eczema-and-atopic-dermatitis-closely-linked
Doug Brunk

Jan 14th, 2022 - An estimated 10% of adults report hand eczema each year, but over one’s lifetime, about 15%-20% will experience the condition, which is more common among those with atopic dermatitis (AD), according to Jacob P. Thyssen, MD, PhD.

Mechanistic modeling of a human IgG4 monoclonal antibody (tralokinumab) Fab-arm exchang...
https://doi.org/10.1002/psp4.12738
CPT: Pharmacometrics & Systems Pharmacology; Wang B, Goodman J et. al.

Jan 14th, 2022 - Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human immunoglobulin G4 (IgG4 ) to form monovalent hybrid molecules. A mechanistic population model was developed to quantitatively characterize the dynamic Fab-arm exchange of...

Allergens and Atopic Dermatitis.
https://doi.org/10.1016/j.anai.2022.01.005
Annals of Allergy, Asthma & Immunology : Official Publica... Wang EA, Leung DYM

Jan 13th, 2022 - Allergens and Atopic Dermatitis.|2022|Wang EA,Leung DYM,|

see more →

Guidelines  9 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Considerations on biologicals for patients with allergic disease in times of the COVID-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.

Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...

European task force on atopic dermatitis position paper: treatment of parental atopic d...
https://doi.org/10.1111/jdv.15709
Journal of the European Academy of Dermatology and Venere... Vestergaard C, Wollenberg A et. al.

Jun 25th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) ...
https://doi.org/10.1111/jdv.14891
Journal of the European Academy of Dermatology and Venere... Wollenberg A, Barbarot S et. al.

Apr 21st, 2018 - This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic revi...

The microbiome in allergic disease: Current understanding and future opportunities-2017...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899886
The Journal of Allergy and Clinical Immunology; Huang YJ, Marsland BJ et. al.

Mar 5th, 2017 - PRACTALL is a joint initiative of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology to provide shared evidence-based recommendations on cutting-edge topics in the field of allergy and ...

see more →

Drugs  448 results see all →

Clinicaltrials.gov  331 results

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)
https://clinicaltrials.gov/ct2/show/NCT04773600

Jan 13th, 2022 - This is a parallel group, double blind, vehicle-controlled study in which ARQ-151 cream or vehicle is applied once daily for 4 weeks to subjects with atopic dermatitis.

Effects of Treatments on Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT01631617

Jan 12th, 2022 - BACKGROUND: The use of antibiotics has revolutionized medicine, yet the impact of antimicrobials on the human microbiome is incompletely understood. Antimicrobial treatments, including topical and systemic antibiotics, are highly effective and are...

Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT03252340

Jan 12th, 2022 - Participants will be followed-up for adverse events on each visit. Visits will be on 6, 12, 18, 24, 30, 36, 48, 60months after treatment of ADSTEM Inj. Time perspective is both retrospective and prospective.

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.
https://clinicaltrials.gov/ct2/show/NCT04922021

Jan 11th, 2022 - This is a clinical study in adult participants with moderate to severe atopic dermatitis (AD). The purpose of the study is to test a new medicine (LEO 138559) given by injection to see if it works to treat AD and what the side effects are when com...

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)
https://clinicaltrials.gov/ct2/show/NCT04921969

Jan 11th, 2022 - The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children with Atopic Dermatitis. This is a randomized, double-blind, Vehicle Controlled study. Participants will be randomized 2:2:1 to blinded treatment with ru...

see more →

News  893 results

Hand eczema and atopic dermatitis closely linked
https://www.mdedge.com/dermatology/article/250751/atopic-dermatitis/hand-eczema-and-atopic-dermatitis-closely-linked
Doug Brunk

Jan 14th, 2022 - An estimated 10% of adults report hand eczema each year, but over one’s lifetime, about 15%-20% will experience the condition, which is more common among those with atopic dermatitis (AD), according to Jacob P. Thyssen, MD, PhD.

Trending Clinical Topic: Atopic Dermatitis
https://www.medscape.com/viewarticle/966211

Jan 14th, 2022 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook. Find the late...

FDA Approves Two Oral JAK Inhibitors for Moderate-to-Severe Atopic Dermatitis
https://www.medscape.com/viewarticle/966698

Jan 14th, 2022 - The Food and Drug Administration on Jan. 14 approved two oral JAK-1 inhibitors for patients with moderate-to-severe atopic dermatitis (AD) — upadacitinib and abrocitinib — making them the first oral JAK inhibitors available for this indication in ...

Sorting Out Sleep Complaints in Children With AD Can Be Complex
https://www.medscape.com/viewarticle/966482

Jan 12th, 2022 - An estimated 50% of children with atopic dermatitis (AD) struggle with sleep problems, with complaints that vary from sleep fragmentation to restlessness and limb movements, according to Stephen H. Sheldon, DO. "They wake up frequently," Sheldon, ...

Ask These Key Questions About Atopic Dermatitis Sleep Problems
https://www.medscape.com/viewarticle/966278

Jan 7th, 2022 - If you don't think it's important to assess for sleep disorders in your patients with atopic dermatitis (AD), think again. According to Sabra M. Abbott, MD, PhD, professor of neurology at Northwestern University, Chicago, AD is associated with dif...

see more →

Patient Education  15 results see all →